Citi opened a “90-day positive catalyst watch” on shares of Becton Dickinson into the fiscal Q2 earnings print. The analyst says the “significant headwinds” including currency and “outsized” inflation that impacted margins in Q1 should begin to abate while management starts to deliver with scaling ramp of Alaris into the second half of the fiscal year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- AngioDynamics settles litigation with Becton Dickinson
- Upcoming Deadline to Share in Becton, Dickinson and Company (BDX) Class Action Settlement
- 5 Best Healthcare Stocks to Buy in March 2024, According to Analysts
- Becton Dickinson further increases U.S. syringe production
- Becton Dickinson management to meet with Jefferies
